Viewpoints

CME on-demand webinar presented by ASHA | A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Visby will be exhibiting at Emergency Nursing 2022 (ENA), a premier professional nursing conference dedicated to defining the future of emergency nursing through advocacy, education, research, innovation, leadership, and more.

Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.

Join Visby Medical at ACEP 2022, an educational and networking conference hosted by the American College of Emergency Physicians.

Come see Visby Medical at the 28th AACC International CPOCT Symposium, a gathering designed to meet the needs of laboratory professionals.

Visby Medical will exhibit at the 14th Annual ConvUrgent Care Symposium. Since 2008, this conference has gathered healthcare leaders into a community around the increasing consumerization of medical care.

Trichomoniasis, commonly known as “trich,” is one of the most common sexually transmitted infections (STIs). It is caused by a one-celled parasite, Trichomonas vaginalis. Men and women are affected by this infection, but it occurs more often in women.

Watch video highlights from “The Neglected Epidemic: A Panel Discussion about the Value Rapid POC PCR brings to Reproductive Health” panel discussion at the 2022 IDSOG Annual Meeting.

For two great ways to learn about Visby rapid PCR, stop by table #6 or catch the breakfast panel discussion on Thursday, August 4 at 7am, all at Revere Hotel Boston Common in Boston, August 4-6.

2022 AACC will showcase the future of laboratory medicine, which includes Visby Medical rapid PCR for the point of care which can help ease lab backlogs.

Visby brings point-of-care PCR to the deep south with an appearance at NACCHO360.

Offering a high-quality scientific meeting covering all aspects in the field of chlamydia research, this symposium provides an excellent opportunity for specialists and trainees in sexual health, HIV medicine, public health, microbiology, epidemiology and behavioral science to share their ideas and experiences.

Respiratory diseases are a leading cause of death worldwide. Get an overview of the most common respiratory diseases, their causes, and treatments.

COVID, Influenza A and B, and RSV may be similar in symptoms, but they need to be treated differently. Learn the difference here.

Early treatment prevents spreading the infection to others. If you are sexually active, it is important to get tested regularly at your healthcare provider, an urgent care, or other local clinic that specializes in treating these infections. Testing is the only way to know for sure if you have an STI.

Visby Medical Will Exhibit at the APHL 2022 Annual Conference, a hybrid event for the public health laboratory (PHL) community.

Visby Medical will exhibit at the UCA/CUCM 2022 Annual Convention. UCA is a trade and professional association in urgent care with more than 3,700 member centers representing urgent care clinical and business professionals from the United States and abroad.

Visit our booth on the show floor of the NAACOS Spring 2022 Conference to learn about our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.

Visby Medical will be exhibiting at the ACOG Annual Clinical and Scientific Meeting (ACSM). ACSM has long been a gathering of the leading women’s health care experts.

We don’t know. The symptoms of the disease are nonspecific, and many people are not even aware they carry the virus. In fact, the CDC estimates that 40% of people with coronavirus symptoms show no symptoms, with other researchers suggesting the rate may be even higher.

Visit our booth on the show floor or stop by our virtual booth via the ACEP app to set an appointment to learn about our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.

The global COVID-19 pandemic touches and disrupts every aspect of life and livelihood across geographies. Despite progress with public health practices and vaccinations, our personal and professional futures face uncertainty. Inconsistent and ambiguous re-opening procedures hinder a robust return to pre-pandemic routines that can restore productivity and economic health.

With the COVID-19 vaccine being distributed and overall infection rates stabilizing, people are beginning to talk about life after the pandemic. Anxious to get back to some kind of normality, even if it means adopting a new normal that includes continued mask wearing and physical distancing, businesses are making plans to open back up.

PCR’s superpower lies in its super sensitivity, which enables it to sniff out even low levels of a pathogen in minutes. Here’s how it works.

Personal PCR could one day become as common as the common cold. In the future, the device will deliver lab accurate results anywhere and to anyone — forever changing our relationship with diagnostics.

Now that Visby has received EUA for our Personal PCR Test to be deployed in moderate-complexity CLIA-certified labs, we’re taking it to the front line of the fight against COVID-19. Each device is personal to individual patients, with results delivered to a lab technician in less than 30 minutes.